Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0348 in Advanced Solid Tumors
Clinical trial NCT05718219 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05718219
- Sponsor
- Jiangsu Simcere Pharmaceutical Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2025-12-30
- Enrollment
- 408
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.